The Coronavirus Vaccine Is a Negative for Netflix Stock for This Reason

Netflix's (NASDAQ: NFLX) stock price plunged in Monday trading following an announcement from Pfizer that its development of a vaccine for COVID-19 was showing real promise of being effective. While the market rose overall on this news, stocks that had benefited from increased online activity over the past nine months or so fell in price, including Netflix.

However, most investors likely expected pre-pandemic viewing patterns to return once society learned to manage the disease. So, while it's understandable that the stock price dipped on the news, the bigger reason why investors should be concerned about Netflix's stock price is related to something different.

Netflix's real problem lies in its balance sheet -- an ongoing issue that could derail the stock's growth over time.

Continue reading

Source Fool.com